Health and Fitness Health and Fitness
Wed, February 6, 2013
Tue, February 5, 2013
Mon, February 4, 2013
Sun, February 3, 2013
Sat, February 2, 2013
Fri, February 1, 2013
Thu, January 31, 2013
Wed, January 30, 2013
Tue, January 29, 2013
[ Tue, Jan 29th 2013 ] - Market Wire
AtheroNova Launches New Website
Mon, January 28, 2013
Sun, January 27, 2013
Sat, January 26, 2013
Fri, January 25, 2013
Thu, January 24, 2013
Wed, January 23, 2013
Tue, January 22, 2013
Mon, January 21, 2013
Fri, January 18, 2013
Thu, January 17, 2013
Wed, January 16, 2013
[ Wed, Jan 16th 2013 ] - Market Wire
30 pm EST
Tue, January 15, 2013
Mon, January 14, 2013
Fri, January 11, 2013

LED Medical Diagnostics Announces Grant of Options


//health-fitness.news-articles.net/content/2013/ .. ical-diagnostics-announces-grant-of-options.html
Published in Health and Fitness on Monday, January 28th 2013 at 10:00 GMT by Market Wire   Print publication without navigation


January 28, 2013 12:55 ET

LED Medical Diagnostics Announces Grant of Options

BURNABY, BRITISH COLUMBIA--(Marketwire - Jan. 28, 2013) - LED Medical Diagnostics Inc. (TSX VENTURE:LMD) ("LED" or the "Company") announces that it has granted a total of 448,000 incentive stock options to consultants of the Company. Each stock option is exercisable to acquire one Common Share of the Company at $0.40 per share and can be exercised for a 3 year term. The option grants are subject to regulatory approval.

About LED Medical Diagnostics Inc.

Headquartered in Burnaby, British Columbia, Canada, LED Medical Diagnostics Inc. is a leading developer of LED-based visualization technologies for the medical industry. The company is publicly traded on the TSX.V under the symbol LMD.

Through its wholly-owned subsidiary, LED Dental Inc., the company manufactures the VELscope Vx Enhanced Oral Assessment System, the first system in the world to apply tissue fluorescence visualization technology to the oral cavity. VELscope Vx devices are now used to conduct more screenings for oral cancer and other oral diseases than any other adjunctive device. To date, there have been more than 12,000 VELscope Vx systems sold globally and they have been used to perform more than 25 million exams. For more information, visit [ www.velscope.com ].

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.




Publication Contributing Sources